Jaclyn Parris

Ms. Jaclyn Parris

University of Zurich
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2019 in Inorganic Chemistry
Verified
Journal Article
Closed access
TMTian Ma
Tian Ma
PYPeng Yang
Peng Yang
JPJaclyn Parris
Jaclyn Parris
TCTibor Csupász
Tibor Csupász
MLMing-Xing Li
Ming-Xing Li
UKUlrich Kortz
Ulrich Kortz

6 May 2021 in Molecules
Verified
Journal Article
Open access
PDF file
GSGünter Schabert
Günter Schabert
RHRobert Haase
Robert Haase
JPJaclyn Parris
Jaclyn Parris
LPLaura Pala
Laura Pala
ABAdrian Hery Barranco
Adrian Hery Barranco
USUrs Spitz
Urs Spitz
NR+ is a highly effective vitamin B3 type supplement due to its unique ability to replenish NAD+ levels. While NR+ chloride is already on the market as a nutritional supplement, its synthesis is challenging, expensive, and low yielding, making it cumbersome for large-scale industrial production. Here we report the novel crystalline NR+ salts, d/l/dl-hydrogen tartrate and d/l/dl-hydrogen malate. Their high-yielding, one-pot manufacture does not require specific equipment and is suitable for multi-ton scale production. These new NR+ salts seem ideal for nutritional applications due to their bio-equivalence compared to the approved NR+ chloride. In addition, the crystal structures of all stereoisomers of NR+ hydrogen tartrate and NR+ hydrogen malate and a comparison to the known NR+ halogenides are presented.

19 September 2025 in ChemRxiv
Verified
Preprint
Open access
PDF file
JPJaclyn Parris
Jaclyn Parris
GWGiann Wiprächtiger
Giann Wiprächtiger
RHReyhaneh Hooshmandabbasi
Reyhaneh Hooshmandabbasi
CMCaroline Maake
Caroline Maake
Greta PatzkeGreta Patzke
Greta Patzke
Nanoparticles composed of selected polyoxometalates (POMs) and carboxymethyl chitosan (CMC) were prepared, characterized, and tested for anticancer activity to establish structure-activity relationships. Cell viability was investigated immediately after treatment and after 24 h to assess both cell recovery and delayed cytotoxicity. The study focused on three questions: (a) trends in cytotoxicity based on POM nuclearity and heteroatoms, (b) effects of CMC encapsulation strategies on cytotoxicity and cellular uptake, and (c) cell viability after a recovery period. Among polyoxotungstates, [NaP5W30O110]14-, with a high tungsten content, showed the greatest cytotoxicity towards PC-3 cells at low concentrations. [Co4(H2O)2(PW9O34)2]10- demonstrated moderate cytotoxicity with an IC50 of 437 ± 23 μM for MRC-5 cells, compared to 11 ± 0.3 μM for [NaP5W30O110]14-. Both POMs were encapsulated in a CMC matrix, forming nanoparticles of 100-250 nm, and analyzed by FT-IR and Raman spectroscopy, DLS, and cryo-TEM, and tested against MRC-5, PC-3, and HeLa cells. It was found that forming nanoparticles increased the magnitude of cytotoxicity compared to the free POM, especially for the lower end of the concentrations tested. However, ICP-MS analyses did not point to significant differences between the uptake of tungsten in cells treated with 250 μM [Co4(H2O)2(PW9O34)2]10- compared to the corresponding nanoparticle system. Furthermore, we newly monitored the cell viability after a 24 h rest period without treatment, allowing for observations of delayed negative or positive effects on the cells. This thorough approach revealed that the preparative strategy applied for encapsulation of [Co4(H2O)2(PW9O34)2]10- in CMC selectively influences the toxicity against HeLa and PC-3 cells compared to the normal MRC-5 cell line.

22 June 2026 in ChemRxiv
Verified
Preprint
Open access
PDF file
JPJaclyn Parris
Jaclyn Parris
GWGiann Wiprächtiger
Giann Wiprächtiger
CMCaroline Maake
Caroline Maake
GPGreta R. Patzke
Greta R. Patzke
Novel cancer treatments are in high demand, and a wider range of low-cost and easily accessible inorganic compounds along the lines of cisplatin is required. This work proposes polyoxotungstates (POT) and POT-carboxymethyl chitosan (CMC) formulations as anticancer drug candidates and addresses the widely unknown influence of POT nuclearity on anticancer activity. Treating cells with WO 4 2- as a reference achieved statistically similar results to the Keggin-type [PW 12 O 40 ] 3− and lacunary [PW 9 O 34 ] 9− , in regard to their tungsten-normalized IC 50 values. The IC 50 values for each are estimated with a global fit to be 5,470 ± 580 μM tungsten were calculated for cancerous PC-3 cells and 6,040 ± 480 μM tungsten for reference MRC-5 cells. The Preyssler-type POT, [NaP 5 W 30 O 110 ] 14− {NaP 5 W 30 } afforded lower IC 50 values, requiring just. 1.2 mM tungsten (40 μM {NaP 5 W 30 }) for PC-3 cells and 210 μM tungsten (8 μM {NaP 5 W 30 }) for MRC-5 cells. The uptake of tungsten by PC-3 cells, as determined by ICP-MS analysis, is ca. 21 times higher for cells treated with {NaP 5 W 30 } than for Na 2 WO 4 . {NaP 5 W 30 } is also combined with CMC as a drug carrier to enhance the activity, selectivity, and stability of the POT. Nanoparticles could be prepared directly in cell culture media with only slight swelling, affording sizes between 90 and 240 nm, according to DLS. The respective nanoparticles (IC 50 value of 16 μM {NaP 5 W 30 }), as well as a mechanical mixture of {NaP 5 W 30 } with CMC (ca. 2 μM {NaP 5 W 30 }), significantly improved the cytotoxicity towards PC-3 cells compared to pristine {NaP 5 W 30 }. On the other hand, the nanoparticles only slightly increased the toxicity towards the non-cancerous MRC-5 cells (IC 50 of 9 μM {NaP 5 W 30 }) and favorably reduced the toxicity with the mixture (18 μM {NaP 5 W 30 }). This renders the easily accessible mechanical mixture of CMC with {NaP 5 W 30 } or other optional POTs, as opposed to the nanoparticles themselves, a promising starting platform for tests on other cancer cell lines and optimization into effective anticancer agents.